Risk of Melanoma in Patients with Basal Cell Carcinoma: A Population-based Cohort Study
DOI:
https://doi.org/10.2340/actadv.v103.4402Keywords:
basal cell carcinoma, melanoma, malignant melanoma, skin cancer, risk factor, cohort studyAbstract
Basal cell carcinoma is the most prevalent cancer in Caucasians worldwide. The aim of this study was to examine the overall risk of melanoma among patients diagnosed with basal cell carcinoma. This population-based retrospective cohort study included data from January 2010 to December 2018 from the databases of the Clalit Health Maintenance Organization and 2 major pathology laboratories in North District, Israel. The incidence and hazard ratio of melanoma in patients with a diagnosis of basal cell carcinoma were determined. Of 466,700 participants, 51% were women and the mean (standard deviation) follow-up was 6.7 (2.9; range 1–9) years. A total of 3,338 patients were diagnosed with basal cell carcinoma during the study period, 82 of whom subsequently developed melanoma. Patients with basal cell carcinoma had a significantly higher incidence of melanoma than patients without basal cell carcinoma (2.46% vs 0.37%; p < 0.0001). Univariate Cox regression analysis revealed a hazard ratio of 6.6 (95% confidence interval: 3.6–12.1; p < 0.0001) for melanoma in patients with a diagnosis of basal cell carcinoma. In conclusion, a diagnosis of basal cell carcinoma confers a significant risk of melanoma.
Downloads
References
Lomas AL, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012; 166: 1069-1080.
https://doi.org/10.1111/j.1365-2133.2012.10830.x DOI: https://doi.org/10.1111/j.1365-2133.2012.10830.x
Hoban PR, Ramachandran S, Strange RC. Environment, phenotype and genetics: risk factors associated with BCC of the skin. Expert Rev Anticancer Ther 2002; 2: 570-579.
https://doi.org/10.1586/14737140.2.5.570 DOI: https://doi.org/10.1586/14737140.2.5.570
Ramachandran S, Fryer AA, Smith AG, Lear JT, Bowers B, Griffiths CE, et al. Basal cell carcinoma. Cancer 2000; 89: 1012-1018.
https://doi.org/10.1002/1097-0142(20000901)89:5<1012::AID-CNCR10>3.0.CO;2-O DOI: https://doi.org/10.1002/1097-0142(20000901)89:5<1012::AID-CNCR10>3.0.CO;2-O
Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994; 30: 774-778.
https://doi.org/10.1016/S0190-9622(08)81509-5 DOI: https://doi.org/10.1016/S0190-9622(08)81509-5
Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199.
https://doi.org/10.1200/JCO.2009.23.4799 DOI: https://doi.org/10.1200/JCO.2009.23.4799
Siskind V, Hughes MC, Palmer JM, Symmons JM, Aitken JF, Martin NG, et al. Nevi, family history, and fair skin increase the risk of second primary melanoma. J Invest Dermatol 2011; 131: 461-467.
https://doi.org/10.1038/jid.2010.298 DOI: https://doi.org/10.1038/jid.2010.298
Tucker MA, Halpern A, Holly EA, Hartge P, Elder DE, Sagebiel RW, et al. Clinically recognized dysplastic nevi: a central risk factor for cutaneous melanoma. JAMA 1997; 277: 1439-1444. DOI: https://doi.org/10.1001/jama.277.18.1439
https://doi.org/10.1001/jama.1997.03540420035026 DOI: https://doi.org/10.1001/jama.1997.03540420035026
Carr S, Smith C, Wernberg J. Epidemiology and risk factors of melanoma. Surg Clin North Am 2020; 100: 1-12.
https://doi.org/10.1016/j.suc.2019.09.005 DOI: https://doi.org/10.1016/j.suc.2019.09.005
Green AC, O'Rourke MG. Cutaneous malignant melanoma in association with other skin cancers. J Natl Cancer Inst 1985; 74: 977-980.
Frisch M, Hjalgrim H, Olsen JH, Melbye M. Risk for subsequent cancer after diagnosis of basal cell carcinoma: a population-based, epidemiologic study. Ann Intern Med 1996; 125: 815-821.
https://doi.org/10.7326/0003-4819-125-10-199611150-00005 DOI: https://doi.org/10.7326/0003-4819-125-10-199611150-00005
Song F, Qureshi AA, Giovannucci EL, Fuchs CS, Chen WY, Stampfer MJ et al. Risk of a second primary cancer after non-melanoma skin cancer in white men and women: a prospective cohort study. PLoS Med 2013; 10: e1001433.
https://doi.org/10.1371/journal.pmed.1001433 DOI: https://doi.org/10.1371/journal.pmed.1001433
Wu S, Cho E, Li WQ, Qureshi AA. History of keratinocyte carcinoma and risk of melanoma: a prospective cohort study. J Natl Cancer Inst 2017; 109: djw268.
https://doi.org/10.1093/jnci/djw268 DOI: https://doi.org/10.1093/jnci/djw268
Flohil SC, van der Leest RJ, Arends LR, de Vries E, Nijsten T. Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis. Eur J Cancer 2013; 49: 2365-2375.
https://doi.org/10.1016/j.ejca.2013.03.010 DOI: https://doi.org/10.1016/j.ejca.2013.03.010
Marghoob AA, Slade J, Salopek TG, Kopf AW, Bart RS, Rigel DS. Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma. Screening implications. Cancer 1995; 75: 707-714. DOI: https://doi.org/10.1002/1097-0142(19950115)75:2+<707::AID-CNCR2820751415>3.0.CO;2-W
https://doi.org/10.1002/1097-0142(19950115)75:2+<707::AID-CNCR2820751415>3.0.CO;2-W
Rees JR, Zens MS, Gui J, Celaya MO, Riddle BL, Karagas MR. Non melanoma skin cancer and subsequent cancer risk. PloS One 2014; 9: e99674.
https://doi.org/10.1371/journal.pone.0099674 DOI: https://doi.org/10.1371/journal.pone.0099674
Levi F, Vecchia CL, Te VC, Randimbison L, Erler G. Incidence of invasive cancers following basal cell skin cancer. Am J Epidemiol 1998; 147: 722-726.
https://doi.org/10.1093/oxfordjournals.aje.a009516 DOI: https://doi.org/10.1093/oxfordjournals.aje.a009516
Karimkhani C, Green AC, Nijsten T, Weinstock MA, Dellavalle RP, Naghavi M, et al. The global burden of melanoma: results from the Global Burden of Disease Study 2015. Br J Dermatol 2017; 177: 134-140.
https://doi.org/10.1111/bjd.15510 DOI: https://doi.org/10.1111/bjd.15510
O'Neill CH, Scoggins CR. Melanoma. J Surg Oncol 2019; 120: 873-881.
https://doi.org/10.1002/jso.25604 DOI: https://doi.org/10.1002/jso.25604
Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, Rosenberg HM, et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 2000; 88: 2398-2424.
https://doi.org/10.1002/(SICI)1097-0142(20000515)88:10<2398::AID-CNCR26>3.0.CO;2-I DOI: https://doi.org/10.1002/(SICI)1097-0142(20000515)88:10<2398::AID-CNCR26>3.0.CO;2-I
Sergentanis TN, Antoniadis AG, Gogas HJ, Antonopoulos CN, Adami HO, Ekbom A et al. Obesity and risk of malignant melanoma: a meta-analysis of cohort and case-control studies. Eur J Cancer 2013; 49: 642-657.
https://doi.org/10.1016/j.ejca.2012.08.028 DOI: https://doi.org/10.1016/j.ejca.2012.08.028
Pothiawala S, Qureshi AA, Li Y, Han J. Obesity and the incidence of skin cancer in US Caucasians. Cancer Causes Control 2012; 23: 717-726.
https://doi.org/10.1007/s10552-012-9941-x DOI: https://doi.org/10.1007/s10552-012-9941-x
Westerdahl J, Olsson H, Måsbäck A, Ingvar C, Jonsson N. Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors. Br J Cancer 1996; 73: 1126-1131.
https://doi.org/10.1038/bjc.1996.216 DOI: https://doi.org/10.1038/bjc.1996.216
Freedman DM, Sigurdson A, Doody MM, Rao RS, Linet MS. Risk of melanoma in relation to smoking, alcohol intake, and other factors in a large occupational cohort. Cancer Causes Control 2003; 14: 847-857.
https://doi.org/10.1023/B:CACO.0000003839.56954.73 DOI: https://doi.org/10.1023/B:CACO.0000003839.56954.73
Sondermeijer L, Lamboo LG, de Waal AC, Galesloot TE, Kiemeney LA, van Rossum M, Aben KH. Cigarette smoking and the risk of cutaneous melanoma: a case-control study. Dermatology 2020; 236: 228-236.
https://doi.org/10.1159/000502129 DOI: https://doi.org/10.1159/000502129
Song F, Qureshi AA, Gao X, Li T, Han J. Smoking and risk of skin cancer: a prospective analysis and a meta-analysis. Int J Epidemiol 2012; 41: 1694-1705.
https://doi.org/10.1093/ije/dys146 DOI: https://doi.org/10.1093/ije/dys146
Kricker A, Armstrong BK, English DR. Sun exposure and non-melanocytic skin cancer. Cancer Causes Control 1994; 5: 367-392.
https://doi.org/10.1007/BF01804988 DOI: https://doi.org/10.1007/BF01804988
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Daniella Kushnir-Grinbaum, Judit Krausz, Nader Rahal, Liat Apel-Sarid, Michael Ziv
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
